CompaniesOncodisc

Oncodisc

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

1

As Collaborator

2

Total Enrollment

758

By Phase

NA: 2PHASE2: 1

By Status

RECRUITING: 1ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT03133273
NCT03515798
NCT05299840
Hover over trial bars to see details

Recent Trials

NCT05299840Lead Sponsor
Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer
NARecruiting
450 participants
Started: Jun 7, 2023 · Completed: Dec 31, 2028
NCT03515798Collaborator
Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer
PHASE2Active, not recruiting
52 participants
Started: Aug 29, 2018 · Completed: Aug 22, 2027
NCT03133273Collaborator
Study of the Therapeutic Response and Survival of Patients with Metastatic Colorectal Cancer (stage IV) and Treated According to the Guidelines of a Chemosensitivity Test, Oncogramme® (ONCOGRAM)
NACompleted
256 participants
Started: Jul 24, 2017 · Completed: Apr 3, 2024
Related Companies
Veris Health
acquired